Effectiveness of Support Resources for Patients with Type 2 Diabetes: A Systematic Review of Clinical Trials in Iran

Authors

  • Atashzadeh-shorideh, Foroozan School of Nursing & Midwifery
  • Ilkhani, Mahnaz School of Nursing & Midwifery
  • Shahsavari, Arezoo School of Nursing & Midwifery
Abstract:

Introduction and Objectives: Type 2 diabetes is a common metabolic disorder worldwide. Health policymakers face challenges in the management of this chronic disease. According to previous studies, due to the complex nature of diabetes, the use of support resources can be effective in improving disease management. The current study aimed to identify the sources of support for patients with type 2 diabetes and to investigate their effectiveness in the outcomes of this disease in Iran. Materials and Methods: In this systematic review, a search of articles published in Iranian databases, including SID, ELMNet, IranDoc, and MagIran, was conducted using keywords, including “type 2 diabetes”, “support resources”, and “clinical trials”, in Persian and English languages from March 21, 2001 to February 9, 2020. Finally, 16 articles were retrieved based on the inclusion criteria. Results: According to the findings, support by family members and peers was the most important source of support for patients with type 2 diabetes in Iran. Also, in most studies, the effectiveness of these support resources was desirable in the outcomes of these patients, including HbA1c, quality of life, and self-care behaviors. Conclusion: The findings of the current study showed that family and peer support for type 2 diabetic patients is the most effective source of support for disease management in Iran. However, to obtain reliable evidence for the use of support resources to improve diabetes management, clinical trials with a stronger methodology are needed.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Cost effectiveness of type 2 diabetes screening: A systematic review

Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.   Methods: We reviewed the MEDLINE, Scopus, Web of Science (WOS), and Cochrane library databases by MeSH terms to identify relevan...

full text

Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review

Introduction: One of the most widely used anti-diabetic drugs is sulfonylureas, which is often used as one of the first-line drugs in the treatment of type 2 diabetes. Due to the effect of the patient's genetic structure on the drug response (personalized medicine), the identification of genetic variations not only reduces the rate of adverse drug reactions but can also predict the effectivenes...

full text

cost effectiveness of type 2 diabetes screening: a systematic review

background: although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. in this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.   methods: we reviewed the medline, scopus, web of science (wos), and cochrane library databases by mesh terms to identify relevant studies fro...

full text

cost effectiveness of type 2 diabetes screening: a systematic review

background: although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. in this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.   methods: we reviewed the medline, scopus, web of science (wos), and cochrane library databases by mesh terms to identify relevant studies fro...

full text

A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing the Safety of Dapagliflozin in Type 1 Diabetes Patients

Background and Purpose: The dapagliflozin’s safety profile in insulin-treated adult type-1 diabetes mellites (T1DM) patients remains poorly explored. Therefore, this systematic review and meta-analysis compared the risk of all-cause side effects, study discontinuation of participants due to side effects, urinary tract infection (UTI), diabetic ketoacidosis, and hypoglycemia between dapagliflozi...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 22  issue 4

pages  279- 294

publication date 2020-12

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023